Frontlight ResearchEarly access
Trial site
University of Alabama/Children's of Alabama
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers6 trials
- Neuroblastoma6 trials
- Sarcoma2 trials
- Phase
- Phase 24 trials
- Phase 1/22 trials
- Phase 11 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed1 trial
- Lead sponsor
- Giselle Sholler4 trials
- Milton S. Hershey Medical Center2 trials
- University of Alabama at Birmingham1 trial
Running trials
Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Active, not recruiting
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Active, not recruiting
Recruiting
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers4 recruiting
- Neuroblastoma4 recruiting
- Sarcoma2 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026